Nuclear data for production of the therapeutic radionuclides (32)p, Cu-64, Cu-67, Sr-89, Y-90 and Sm-153 via (n,p) reactions on the target nuclei S-32, Zn-64, Zn-67, Y-89, Zr-90 and Eu-153, respectively, are discussed. The available information on each excitation function was analysed. From the recommended data set for each reaction the average integrated cross section for a standard 14 MeV d(Be) neutron field was deduced. The spectrum-averaged cross section was also measured experimentally. A comparison of the integrated value with the integral measurement served to validate the excitation function within about 15%. A fast neutron source appears to be much more effective than a fission reactor for production of the above-mentioned radionuclides in a no-carrier-added form via the (n,p) process. In particular, the possibility of production of high specific activity (SM)-S-153 is discussed. (c) 2006 Elsevier Ltd. All rights reserved.
